Eoin Coakley
Enanta Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Hepatitis C virus research, HIV/AIDS Research and Interventions, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin(2014)902 cited
- → An Interferon-free Antiviral Regimen for HCV after Liver Transplantation(2014)402 cited
- → Maraviroc versus Efavirenz, Both in Combination with Zidovudine‐Lamivudine, for the Treatment of Antiretroviral‐Naive Subjects with CCR5‐Tropic HIV‐1 Infection(2010)265 cited
- → Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV‐1–Infected, Treatment‐Experienced Patients: AIDS Clinical Trials Group 5211(2007)239 cited
- → Quantitative Deep Sequencing Reveals Dynamic HIV-1 Escape and Large Population Shifts during CCR5 Antagonist Therapy In Vivo(2009)233 cited
- → HIV Type 1 Chemokine Coreceptor Use among Antiretroviral-Experienced Patients Screened for a Clinical Trial of a CCR5 Inhibitor: AIDS Clinical Trial Group A5211(2007)182 cited
- → A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance Mechanism(2007)167 cited
- → Assessing chemokine co-receptor usage in HIV(2005)144 cited
- → Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine(2000)133 cited
- → Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV(1999)129 cited